Ascendum Capital

Ascendum Capital is a Hong Kong-based investment firm providing growth capital to early-stage companies. It specializes in the biotech and healthtech sectors, primarily across China and global markets. The firm focuses on identifying and supporting innovative businesses, offering both funding and strategic guidance to accelerate their development within the dynamic healthcare industry.

Established in 2020, Ascendum Capital lists Serena Shao as a co-founder and managing partner. The firm's inception was driven by the recognition of a clear opportunity to offer specialized capital and expertise to nascent companies at the forefront of medical science and technology, addressing the unique needs of these early-stage ventures.

The firm's portfolio comprises early-stage enterprises developing novel solutions in biotechnology and health technology. Ascendum Capital aims to be a key financial partner, accelerating medical advancements globally. Its long-term vision is to significantly contribute to the evolution of global healthcare by strategically investing in groundbreaking innovation.